Researchers Make Progress Toward Identifying C.t.e. In The Living
THE NEW YORK TIMES
By Ken Belson
One of the frustrations of researchers who study chronic traumatic encephalopathy (CTE), the degenerative brain disease linked to repeated head hits, is that it can be detected only in autopsies, and not in the living.
Researchers, though, have been trying to solve this problem in two primary ways: by identifying biomarkers linked to the disease that show up on imaging tests in certain locations in the brain, and by trying to locate in the blood the protein that is the hallmark of the disease.
At a medical conference in Boston on Monday, Robert Stern, a professor of neurology at Boston University, said technology developed by the company Quanterix (paid for in part with a grant from the N.F.L.) had identified elevated levels of tau proteins in blood samples of 96 former football players between 40 and 69 years old, compared with only 25 people of the same age in a control group.
Read the remainder of the article at The New York Times .
Share this page